8 Results for "

hyperammonemia

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "hyperammonemia" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0711
CAS No.: 1188-38-1
Synonyms: N-Carbamyl-L-glutamic acid
Research Areas:  

Infection Cancer

Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.
loading...
    loading...
Cat. No.: HY-154021A
CAS No.: 124796-41-4
Purity:  99.08%
Synonyms: 5-FMOrn dihydrochloride
Research Areas:  

Metabolic Disease

5-Fluoromethylornithine dihydrochloride (5-FMOrn dihydrochloride) is an orally active and blood-brain barrier-penetrant irreversible inhibitor of ornithine aminotransferase (OAT). 5-Fluoromethylornithine dihydrochloride competes with ornithine at the OAT active site and acts as a poor substrate for ornithine decarboxylase (ODC), competitively reducing ornithine decarboxylation, elevating tissue ornithine, and thereby affecting polyamine metabolism . 5-Fluoromethylornithine dihydrochloride attenuates Thioacetamide (HY-Y0698)-induced acute liver injury-related pathological changes . 5-Fluoromethylornithine dihydrochloride is used in research on acute liver injury and hyperammonemia .
loading...
    loading...
Cat. No.: HY-158161
CAS No.: 3032920-98-9
Research Areas:  

Metabolic Disease

JN-170 is a potent and highly selective inhibitor and transport corrector of human SLC6A19 (IC50=47 nM). Furthermore, at a concentration of 35 μM, JN-170 exhibits no activity against SLC1A5, SLC7A5, or SLC6A8. JN-170 is applicable to research on phenylketonuria (PKU) and hyperphenylalaninemia. JN-170 is also suitable for studies related to various metabolic disorders, including tyrosinemia, maple syrup urine disease, urea cycle disorders, and hyperammonemia .
loading...
    loading...
Cat. No.: HY-B0711R
CAS No.: 1188-38-1
Synonyms: N-Carbamyl-L-glutamic acid (Standard)
Carglumic Acid (Standard) is the analytical standard of Carglumic Acid. This product is intended for research and analytical applications. Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.
loading...
    loading...
Cat. No.: HY-131275R
CAS No.: 1365802-18-1
Research Areas:  

Others

Carglumic Acid (Standard) is the analytical standard of Carglumic Acid. This product is intended for research and analytical applications. Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.
loading...
    loading...
Cat. No.: HY-B1713
CAS No.: 616-07-9
Synonyms: (±)-Ornithine
Ornithine ((±)-Ornithine) is a non-essential amino acid. Ornithine is an intermediate in urea cycle and acts as a substrate for these rate limiting enzymes ornithine transcarbomylase, ornithine aminotransferase and ornithine decarboxylase producing citrulline, proline and polyamines, respectively. Ornithine can be used in the research of hyperornithinemia, hyperammonemia, and cancer .
loading...
    loading...
Cat. No.: HY-131691
CAS No.: 76991-05-4
Target:  

iGluR Calcium Channel

Research Areas:  

Neurological Disease

NMDAR blocker 1 is an NMDA receptor channel blocker with an IC50 of 5.0 μM. NMDAR blocker 1 exhibits fast on-off blockade kinetics and strong voltage dependence, and does not compete with glutamate or glycine. NMDAR blocker 1 prevents glutamate/NMDA-induced intracellular Ca 2+ overload, modulates the glutamate-nitric oxide-cGMP pathway. NMDAR blocker 1 prevents in vitro excitotoxic neurodegeneration of cultured cerebellar and hippocampal neurons. NMDAR blocker 1 attenuates excitotoxic insult in an mouse model of hyperammonemia-induced excitotoxicity. NMDAR blocker 1 can be used for the research of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-L189
352 compounds

Amino acids, as one of the most fundamental organic compounds in living organisms, serve not only as the basic building blocks of proteins but also but also undertake the functions of energy supply, neurotransmitter synthesis, and maintenance of internal environment stability.Amino acid metabolic enzymes are a class of enzymes involved in the metabolic processes of amino acids, catalyzing their synthesis, breakdown, transformation, and interactions with other metabolic pathways. Abnormalities in amino acid metabolic enzymes can lead to various metabolic diseases, such as phenylketonuria and hyperammonemia, etc. Therefore, actively exploring and regulating the processes of amino acid metabolism is crucial for the development of drugs related to these diseases.

MCE designs a unique collection of 352 small molecules target amino acid metabolizing enzymes, which is an important tool for studying studying amino acid metabolism processes or metabolism-related drug development.